Pseudogenes are stretches of DNA that resemble functional genes but carry mutations that, in most cases, prevent them from producing a working protein. For decades they were dismissed as “junk DNA,” genomic relics left behind by evolution with no useful role. That view has changed sharply. Research over the past two decades shows that many pseudogenes are transcribed into RNA, that some of those transcripts regulate the activity of other genes, and that a few pseudogenes even produce small proteins. Far from being inert, pseudogenes turn out to be a surprisingly active part of the genome with real consequences for health, disease, and how organisms evolve.
How Pseudogenes Form
A pseudogene begins as a normal, working gene. Something then breaks it. The break can happen in a few different ways, and the route matters because it determines what the pseudogene looks like and where it ends up in the genome.
The most straightforward route is simple decay. A gene accumulates random mutations over generations, picking up premature stop signals or deletions that prevent it from making a complete protein. Because the broken copy stays right where the original gene sat, surrounded by the same neighboring DNA, these are called “unprocessed” pseudogenes. They still look a lot like their parent gene, introns and all.
A second route involves a detour through RNA. A working gene gets transcribed into messenger RNA, that RNA gets reverse-transcribed back into DNA by the molecular machinery of a jumping gene called LINE-1, and the new DNA copy gets inserted somewhere else in the genome.1PubMed Central. Retroposition of processed pseudogenes: the impact of RNA stability and translational control Because the RNA was already processed before it was copied, the resulting pseudogene lacks the introns and regulatory sequences needed to be properly switched on. These “processed” pseudogenes are scattered more or less randomly across chromosomes, and the human genome contains thousands of them.
A third category stands apart. Unitary pseudogenes have no working counterpart left in the genome at all. The original gene broke and nothing replaced it.2PubMed Central. Identification and analysis of unitary pseudogenes: historic and contemporary gene losses in humans and other primates The function it once performed was either picked up by another gene, became unnecessary, or was simply lost. These are genuine one-way tickets: the organism can never get that gene back through its own lineage.
Molecular Fossils That Tell Evolutionary Stories
Because pseudogenes accumulate mutations at a roughly steady rate once freed from the pressure to stay functional, they act as molecular clocks. Comparing the same pseudogene across species lets researchers estimate when two lineages diverged and, more interestingly, when a particular biological capability was lost.
Olfactory receptor genes offer one of the best-studied examples. Humans carry hundreds of olfactory receptor genes, but roughly half of them are pseudogenes in hominoids, compared with about 27% in Old World monkeys and almost none in mice.3PubMed. The olfactory receptor gene repertoire in primates and mouse: evidence for reduction of the functional fraction in primates The pattern suggests that as primates evolved and came to depend more heavily on vision, the selective pressure keeping all those smell receptors working relaxed. Research further indicates that primates with full trichromatic color vision tend to have more olfactory pseudogenes, hinting at a trade-off between the importance of color sight and the importance of smell.4PLOS Biology. Loss of Olfactory Receptor Genes Coincides with the Acquisition of Full Trichromatic Vision in Primates Additional analysis has connected the extent of leaf-eating in primates with a smaller number of functional olfactory receptor genes, suggesting that diet also plays a role in which receptors stay useful and which decay.5Molecular Biology and Evolution. Acceleration of Olfactory Receptor Gene Loss in Primate Evolution: Possible Link to Anatomical Change in Sensory Systems and Dietary Transition
The vitamin C story is another classic. Most mammals synthesize their own vitamin C, but humans, other higher primates, guinea pigs, and certain bats cannot. In every case studied, the culprit is the same: the gene for the enzyme that catalyzes the final step of vitamin C production, called GULO, has been wrecked by mutations.6PubMed Central. The genetics of vitamin C loss in vertebrates The broken copies in these species carry multiple insertions, deletions, and premature stop codons, making them textbook unitary pseudogenes.7PubMed. Conserved or lost: molecular evolution of the key gene GULO in vertebrate vitamin C biosynthesis The fact that the same gene broke independently in several unrelated lineages suggests that animals with fruit-rich diets could afford to lose the ability to make vitamin C internally, because they were getting plenty from food. The pseudogene is the receipt for that evolutionary transaction.
When “Dead” Genes Still Do Things
The old assumption was that pseudogenes, lacking the ability to produce functional proteins, could not influence anything. That turns out to be wrong in several interesting ways.
One of the best-documented mechanisms involves a pseudogene acting as a decoy for regulatory molecules. The tumor-suppressor gene PTEN has a pseudogene called PTENP1 whose transcript shares extensive sequence similarity with PTEN’s own messenger RNA. Because the two transcripts look so alike, small regulatory RNA molecules called microRNAs that would normally latch onto PTEN and suppress it get diverted to PTENP1 instead.8PubMed Central. PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics The pseudogene acts as a sponge, soaking up the microRNAs and effectively boosting the amount of PTEN protein the cell makes. This sponging effect has been shown to matter in contexts beyond cancer: one study found that PTENP1 influences bone-cell behavior by intercepting a specific microRNA that would otherwise suppress PTEN in osteoclasts.9PubMed. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis
Pseudogenes also participate in gene regulation through a completely different route. In mouse egg cells, transcripts from pseudogenes pair up with transcripts from their parent genes to form double-stranded RNA, which gets chopped into small interfering RNAs that silence specific genes.10PubMed Central. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes This is a fundamentally different mechanism from the sponging described above, but the outcome is similar: a pseudogene that cannot make a protein still controls how much protein its parent gene produces.
Some Pseudogenes Actually Make Proteins
The finding that surprised the field most was evidence that some pseudogenes are not just transcribed but translated. Ribosome profiling studies, which track where the cell’s protein-making machinery sits on RNA, have detected active translation on pseudogene transcripts. Work in the plant Arabidopsis found that certain pseudogene transcripts carry small open reading frames that are evolutionarily conserved and produce stable proteins.11PubMed Central. Super-resolution ribosome profiling reveals unannotated translation events in Arabidopsis Similar signals have been found in human cells, where ribosome profiling and mass spectrometry data indicate that some pseudogene-derived open reading frames do yield peptides, though what many of those peptides do remains unclear.12eLife. Many lncRNAs, 5’UTRs, and pseudogenes are translated and some are likely to express functional proteins
A recent proteomics analysis pushed the point further, reporting that roughly a quarter of the noncanonical proteins detected in large-scale datasets are encoded by pseudogenes.13PubMed Central. Proteomics Can Rise to the Challenge of Pseudogenes’ Coding Nature That does not mean a quarter of pseudogenes are secretly functional. Many produce nothing. But the fraction that does produce something is large enough that treating pseudogenes as universally inert is no longer defensible.
Pseudogenes and Cancer
Given that pseudogenes can regulate gene expression and occasionally produce proteins, it follows that when their behavior goes wrong, disease can result. Cancer has drawn the most attention. Pseudogenes are frequently expressed at abnormal levels in tumors, and integrative analyses of cancer data have shown that pseudogene-derived DNA, RNA, and proteins can interfere with the function of oncogenes and tumor suppressors.14PubMed. Pseudogenes as Biomarkers and Therapeutic Targets in Human Cancers In colorectal, liver, lung, and gastric cancers, the majority of prognostic pseudogenes identified so far are overexpressed and appear to play an oncogenic role.
The PTENP1 example illustrates how this can work mechanistically. If PTENP1 is silenced or deleted in a tumor, it can no longer sponge up the microRNAs that suppress PTEN. PTEN levels drop, and one of the cell’s key brakes on growth is weakened. The pseudogene’s silence, in other words, can be just as consequential as a mutation in the tumor suppressor itself. Researchers are now investigating whether pseudogene expression patterns could serve as biomarkers for diagnosis or prognosis, and whether restoring pseudogene function could offer a therapeutic angle.15PubMed Central. Pseudogenes in Cancer: State of the Art
The Diagnostic Headache
Pseudogenes create a very practical problem for genetic testing. Modern DNA sequencing works by reading short fragments and then assembling them by matching overlapping pieces. When a pseudogene is nearly identical to the real gene a lab is trying to test, fragments from the pseudogene can get mixed in with fragments from the functional gene, leading to false results.16PubMed. Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era The higher the similarity between a pseudogene and its parent, the worse the problem gets.
This is not a theoretical concern. The gene IKBKG, linked to a group of primary immunodeficiency disorders, has a pseudogene called IKBKGP1 that is so similar to the real gene that standard capture methods pull in both, making it difficult to tell which variants belong where.17PubMed. Conventional and Single-Molecule Targeted Sequencing Method for Specific Variant Detection in IKBKG while Bypassing the IKBKGP1 Pseudogene A patient could receive a false-positive result, suggesting they carry a disease-causing mutation that actually sits in the harmless pseudogene, or a false-negative result, where a real mutation hides behind pseudogene noise. Special sequencing strategies have been developed to work around the problem, but they require labs to know the pseudogene is there in the first place.
Congenital adrenal hyperplasia offers another example. The most common form of this condition is caused by mutations in the CYP21A2 gene, and one of the main mechanisms behind those mutations is gene conversion, in which sequences from a nearby pseudogene overwrite parts of the working gene.18Fertility and Sterility. Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation Here, the pseudogene is not just confusing the diagnostic test; it is actively causing the disease by donating its broken sequences to the functional gene.
Pseudogenes as Weapons for Parasites
The trypanosome parasites that cause sleeping sickness in Africa have turned pseudogenes into a survival strategy. These single-celled organisms coat their surface with a protein called VSG (variant surface glycoprotein) and periodically swap it for a different version, staying one step ahead of the host immune system.19PubMed Central. Emerging challenges in understanding trypanosome antigenic variation The trypanosome genome carries a large archive of VSG genes, many of which are pseudogenes that cannot be expressed on their own.
But the parasite has a workaround. It stitches together fragments from multiple pseudogenes to create mosaic VSG genes that are functional. One study found that about 42% of the donors for the variable portion of these mosaic genes were pseudogenes.20PLOS Pathogens. Mosaic VSGs and the Scale of Trypanosoma brucei Antigenic Variation This means the parasite’s pseudogenes are not dead weight; they are a reservoir of antigenic diversity, giving the trypanosome far more surface-coat options than it would have from intact genes alone. It is one of the more elegant examples of how pseudogenes can be co-opted for an active biological purpose, even if the “purpose” in this case benefits a pathogen rather than its host.
Resurrection and Reinvention
One of the more provocative ideas in pseudogene biology is that a pseudogene can sometimes come back to life. Because pseudogenes are freed from the selective pressure to stay functional, they can mutate freely. Most of the time, those mutations dig the pseudogene deeper into nonfunctionality. Occasionally, though, a mutation happens to restore the reading frame or introduce a useful new function.21PubMed Central. From Genomic Fossils to Functional Elements: The Evolving Story of Pseudogenes
A striking case was described in petunias. The loss of purple flower color in certain petunia species was traced to repeated pseudogenization of a gene called AN2. But in one species, Petunia secreta, a single mutation restored the reading frame of an AN2 ancestor that had been nonfunctional, bringing purple pigmentation back.22Current Biology. AN2 and MYB-FL Provide a Molecular Mechanism for Flower Color Reversal in Petunia The researchers called it an “improbable resurrection,” and it illustrates a broader principle: pseudogenes are not necessarily evolutionary dead ends. They can serve as raw material from which new functions emerge.
Some genes that were once thought to have arisen completely from scratch, so-called de novo genes, may have actually originated from pseudogenes or retro-duplicated sequences that were later reactivated. The antifreeze glycoprotein found in certain fish, long held up as a textbook example of a de novo gene, may have evolved from a pseudogenized apolipoprotein that was later repurposed.23PubMed. Four classic “de novo” genes all have plausible homologs and likely evolved from retro-duplicated or pseudogenic sequences If this pattern turns out to be common, pseudogenes may function as a kind of genomic sandbox where experimental sequences can mutate and occasionally stumble into something useful.
Polymorphic Pseudogenes and the Blurry Line Between Gene and Pseudogene
The boundary between a gene and a pseudogene is not always clear-cut, especially when you look across human populations. Some loci exist in a state of flux: certain people carry a working copy and others carry a version with a loss-of-function mutation. These are called polymorphic pseudogenes, and they are found both in heterozygous and homozygous states in different populations.24PubMed Central. Polymorphic pseudogenes in the human genome – a comprehensive assessment
This matters because it means the distinction between “gene” and “pseudogene” can depend on which individual’s genome you are reading. A locus annotated as a pseudogene in the reference genome might be a perfectly functional gene in a large fraction of the world’s population, or vice versa. For researchers trying to catalog gene function, and for clinicians interpreting genetic test results, this ambiguity is a real problem. A variant flagged as irrelevant because it sits in a “pseudogene” could turn out to be meaningful if that pseudogene is actually functional in the patient being tested.
Polymorphic pseudogenes also offer a window into evolution in real time. They represent genes that are in the process of being lost, or possibly gained. Whether the loss-of-function allele drifts to fixation, gets eliminated, or persists indefinitely at some intermediate frequency depends on whether losing that gene carries a fitness cost, confers an advantage, or makes no difference at all. Studying which genes are in this transitional state, and in which populations, helps geneticists understand the selective pressures acting on different human groups today.
Pseudogenes and the Liquid Interior of the Cell
One of the newer and more speculative areas of pseudogene research involves their connection to liquid-liquid phase separation, the process by which certain molecules inside cells spontaneously cluster into droplet-like compartments without a membrane. These compartments concentrate specific proteins and RNA molecules, and they play roles in everything from gene transcription to how RNA is processed after it is made. Recent work suggests that RNAs and peptides produced by pseudogenes can influence the formation of these condensates, potentially affecting gene expression at an epigenetic level. Pseudogene-derived long noncoding RNAs, for instance, have been found at higher levels in tumor cells than in normal tissue, and their involvement in phase-separated compartments could help explain how they contribute to abnormal gene regulation in cancer.
The research here is still early, and it would be premature to draw firm conclusions about how big a role this plays in normal biology versus disease. But the fact that pseudogenes are even being discussed in the context of cellular organization, a domain far removed from the “junk DNA” label they carried for decades, speaks to how dramatically the field’s understanding of these sequences has shifted. The genome, it turns out, keeps more of its old parts in service than anyone expected.